Now, keep up to date
with daily feeds of newly posted stories
about America's Seniors...click on the box
to the left
Nitroglycerin Boosts Bone Density and Bone
Strength
Newswise , February 22, 2011 – Nitroglycerin
is best known as a high explosive or a
treatment for angina, but a new study in the
February 23rd issue of the Journal of the
American Medical Association says
it may also be an effective therapy to
strengthen bones and treat osteoporosis.
“Our findings demonstrate that nitroglycerin
ointment, in very low doses, can increase
bone density and improve bone geometry,”
says Sophie A Jamal, MD, PhD of the Women’s
College Research Institute and University of
Toronto, Canada, and the lead author of the
study.
“Nitrates are widely available and
inexpensive. As such these agents might be a
promising way to reduce osteoporosis world
wide.”
“This is an exciting new treatment that is
unlike any other drugs now used for
osteoporosis,” says Steven R. Cummings, MD,
of the San Francisco Coordinating Center at
the California Pacific Medical Center
Research Institute, and the senior author of
the study.
“While other treatments work by either
slowing the breakdown of bone, or increasing
bone formation, nitroglycerin does both at
the same time.
“It’s a unique quality that leads to an
apparent increase in bone strength.”
Jamal, Cummings, and researchers at the
University of Toronto, Canada, followed 243
postmenopausal women for 24 months in a
single center, double-blind, placebo
controlled study.
The women, none of whom had osteoporosis,
were randomly assigned to receive either
nitroglycerin ointment or a placebo. They
pasted the ointment onto their skin at
bedtime.
At the end of the two year study women who
were assigned to the nitroglycerin ointment
group saw an increase of 7 percent in the
bone mineral density (BMD) in their hip
bones compared to women who were given a
placebo. BMD indicates bone quantity- a
strong indicator of fracture risk.
“One of the most striking effects was the
increase in cortical width or the thickness
of the bone,” say Jamal and Cummings.
“The nitroglycerin group saw an increase of
almost 25 percent in their legs and an
increase of 15 percent in their arms,
compared to the placebo group. This was
unexpected because it’s not something you
see with existing therapies.”
There were some side effects of the
treatment: about 25% of women had headaches
with nitroglycerin and did not participate
in the study. Of women who were enrolled,
about 5% stopped because of headache.
The researchers say the results from the
study are very encouraging but further
larger trials are needed, both to replicate
these findings and to determine the effects
on fracture, before any treatment
recommendations can be made.
Because nitroglycerin is not a patented
product further research would most likely
involve the support of, and funding from,
the National Institutes of Health.